NLRP3诱导的全身炎症控制了JAK2V617F突变骨髓增殖性瘤的发展
Ruth-Miriam Koerber1,2,3, Calvin Krollmann1,3, Kevin Cieslak1,3
1Department of Medicine III, University Hospital Bonn, Bonn, Germany.
Nature communications
|November 26, 2025
概括
这种NLRP3炎症体通过促进炎症和细胞生长来驱动骨髓增殖性瘤 (MPN). 在已确定的MPN中抑制NLRP3可以逆转疾病进展,这表明了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 骨髓增殖性瘤 (MPN) 涉及炎症,但先天免疫传感器的作用尚不清楚.
- NLRP3炎症酶激活检测细胞压力,并与炎症性疾病有关.
研究的目的:
- 为了调查NLRP3炎症酶激活是否驱动小鼠JAK2V617F突变MPN.
- 评估NLRP3抑制在MPN中的治疗潜力.
主要方法:
- 使用了JAK2V617F突变MPN的小鼠模型.
- 评估了在造血细胞中NLRP3缺失对MPN发育的影响.
- 研究了药理NLRP3阻断对已确定的MPN的影响.
主要成果:
- 删除NLRP3阻止了MPN中的IL-1β和IL-18释放.
- NLRP3促进了血栓细胞形成,粒细胞形成和HSC/原始细胞扩张.
- 激活NLRP3增强了骨髓纤维化和脊髓巨变.
- 药物学NLRP3阻断逆转了血栓细胞瘤,壮和纤维化.
结论:
- NLRP3炎症酶对MPN的发病过程至关重要.
- 抑制NLRP3是MPN的一种有前途的治疗策略.
相关概念视频
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


